Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.59 USD | -0.34% | +3.34% | -5.61% |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Revenues | 287M | 431M | 656M | 975M | 1.3B | |||
Total Revenues | 287M | 431M | 656M | 975M | 1.3B | |||
Cost of Goods Sold, Total | 63.42M | 101M | 147M | 233M | 307M | |||
Gross Profit | 224M | 330M | 509M | 743M | 990M | |||
Selling General & Admin Expenses, Total | 241M | 303M | 447M | 642M | 817M | |||
R&D Expenses | 90.67M | 127M | 189M | 298M | 358M | |||
Other Operating Expenses, Total | 332M | 430M | 637M | 940M | 1.18B | |||
Operating Income | -108M | -100M | -127M | -197M | -185M | |||
Interest Expense, Total | -1.11M | -24.96M | -49.23M | -4.98M | -5.87M | |||
Interest And Investment Income | 5.79M | 6.59M | 1.97M | 14.88M | 68.17M | |||
Net Interest Expenses | 4.68M | -18.38M | -47.26M | 9.89M | 62.3M | |||
Currency Exchange Gains (Loss) | -200K | -900K | -400K | 2M | - | |||
Other Non Operating Income (Expenses) | -1.24M | 1.07M | -394K | -1.42M | -4.37M | |||
EBT, Excl. Unusual Items | -105M | -119M | -175M | -187M | -128M | |||
Merger & Related Restructuring Charges | - | -6.28M | -380K | -3.95M | - | |||
Other Unusual Items | - | - | -72.23M | - | -50.3M | |||
EBT, Incl. Unusual Items | -105M | -125M | -248M | -191M | -178M | |||
Income Tax Expense | 1.12M | -5.6M | 12.33M | 2.65M | 6.09M | |||
Earnings From Continuing Operations | -106M | -119M | -260M | -193M | -184M | |||
Net Income to Company | -106M | -119M | -260M | -193M | -184M | |||
Net Income - (IS) | -106M | -119M | -260M | -193M | -184M | |||
Net Income to Common Incl Extra Items | -106M | -119M | -260M | -193M | -184M | |||
Net Income to Common Excl. Extra Items | -106M | -119M | -260M | -193M | -184M | |||
Per Share Items | ||||||||
Net EPS - Basic | -0.72 | -0.4 | -0.83 | -0.59 | -0.55 | |||
Basic EPS - Continuing Operations | -0.72 | -0.4 | -0.83 | -0.59 | -0.55 | |||
Basic Weighted Average Shares Outstanding | 146M | 300M | 312M | 326M | 334M | |||
Net EPS - Diluted | -0.72 | -0.4 | -0.83 | -0.59 | -0.55 | |||
Diluted EPS - Continuing Operations | -0.72 | -0.4 | -0.83 | -0.59 | -0.55 | |||
Diluted Weighted Average Shares Outstanding | 146M | 300M | 312M | 326M | 334M | |||
Normalized Basic EPS | -0.45 | -0.25 | -0.35 | -0.36 | -0.24 | |||
Normalized Diluted EPS | -0.45 | -0.25 | -0.35 | -0.36 | -0.24 | |||
Supplemental Items | ||||||||
EBITDA | -85.29M | -66.8M | -81.5M | -115M | -71.16M | |||
EBITA | -108M | -100M | -127M | -182M | -165M | |||
EBIT | -108M | -100M | -127M | -197M | -185M | |||
EBITDAR | -74.09M | -50.09M | -57.5M | -78.79M | -26.37M | |||
Effective Tax Rate - (Ratio) | -1.06 | 4.48 | -4.97 | -1.39 | -3.42 | |||
Current Domestic Taxes | 420K | 554K | 865K | 333K | 837K | |||
Current Foreign Taxes | 325K | 769K | 2.73M | 2.46M | 2.99M | |||
Total Current Taxes | 745K | 1.32M | 3.6M | 2.79M | 3.82M | |||
Deferred Domestic Taxes | - | -781K | - | -1.7M | - | |||
Deferred Foreign Taxes | 370K | -6.14M | 8.74M | 1.56M | 2.26M | |||
Total Deferred Taxes | 370K | -6.93M | 8.74M | -140K | 2.26M | |||
Normalized Net Income | -65.45M | -74.18M | -110M | -117M | -79.73M | |||
Interest on Long-Term Debt | - | 24.34M | 49.34M | 5.86M | 5M | |||
Supplemental Operating Expense Items | ||||||||
Advertising Expense | 18.8M | 25M | 36.2M | 43.5M | 57.6M | |||
Selling and Marketing Expenses | 159M | 218M | 328M | 466M | 599M | |||
General and Administrative Expenses | 81.58M | 85.47M | 119M | 176M | 218M | |||
Research And Development Expense From Footnotes | 97.47M | 143M | 210M | 319M | 380M | |||
Net Rental Expense, Total | 11.2M | 16.72M | 24M | 36.33M | 44.79M | |||
Imputed Operating Lease Interest Expense | 9.4M | 15.21M | 10.98M | 1.01M | 1.4M | |||
Imputed Operating Lease Depreciation | 1.8M | 1.5M | 13.02M | 35.32M | 43.4M | |||
Stock-Based Comp., COGS (Total) | 716K | 1.22M | 2.58M | 6.25M | 7.97M | |||
Stock-Based Comp., R&D Exp. (Total) | 13.04M | 26.09M | 44.2M | 103M | 132M | |||
Stock-Based Comp., S&M Exp. (Total) | 8.71M | 16.02M | 27.28M | 50.32M | 73.68M | |||
Stock-Based Comp., G&A Exp. (Total) | 14.16M | 13M | 16.08M | 42.93M | 59.92M | |||
Total Stock-Based Compensation | 36.63M | 56.33M | 90.14M | 203M | 274M |